199 related articles for article (PubMed ID: 34011519)
1. The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D
Chen W; Luo J; Ye Y; Hoyle R; Liu W; Borst R; Kazani S; Shikatani EA; Erpenbeck VJ; Pavord ID; Klenerman P; Sandham DA; Xue L
J Immunol; 2021 Jun; 206(11):2714-2724. PubMed ID: 34011519
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin D
Carstensen S; Gress C; Erpenbeck VJ; Kazani SD; Hohlfeld JM; Sandham DA; Müller M
Respir Res; 2021 Oct; 22(1):262. PubMed ID: 34620168
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
4. DP
Saunders R; Kaul H; Berair R; Gonem S; Singapuri A; Sutcliffe AJ; Chachi L; Biddle MS; Kaur D; Bourne M; Pavord ID; Wardlaw AJ; Siddiqui SH; Kay RA; Brook BS; Smallwood RH; Brightling CE
Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760581
[TBL] [Abstract][Full Text] [Related]
5. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
Sykes DA; Bradley ME; Riddy DM; Willard E; Reilly J; Miah A; Bauer C; Watson SJ; Sandham DA; Dubois G; Charlton SJ
Mol Pharmacol; 2016 May; 89(5):593-605. PubMed ID: 26916831
[TBL] [Abstract][Full Text] [Related]
6. Fevipiprant, a DP
Shamri R; Dubois G; Erpenbeck VJ; Mankuta D; Sandham DA; Levi-Schaffer F
Clin Exp Allergy; 2019 Feb; 49(2):255-257. PubMed ID: 30379368
[No Abstract] [Full Text] [Related]
7. The prostaglandin D
Domingo C; Palomares O; Sandham DA; Erpenbeck VJ; Altman P
Respir Res; 2018 Sep; 19(1):189. PubMed ID: 30268119
[TBL] [Abstract][Full Text] [Related]
8. Leptin Elicits LTC
Amorim NRT; Luna-Gomes T; Gama-Almeida M; Souza-Almeida G; Canetti C; Diaz BL; Weller PF; Torres Bozza P; Maya-Monteiro CM; Bandeira-Melo C
Front Immunol; 2018; 9():2139. PubMed ID: 30298073
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
Zhang S; Wu X; Yu S
Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
[TBL] [Abstract][Full Text] [Related]
10. Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
Skrtic S; Tyrberg B; Broberg M; Ericsson H; Schnecke V; Kjaer M; Hompesch M; Andersson EM; Ryberg E; Aivazidis A; Wennberg Huldt C; Löfgren L; Morrow L; Parkinson J; Rydén-Bergsten T; Watkins E; Sörhede Winzell M
PLoS One; 2018; 13(12):e0208998. PubMed ID: 30557325
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2.
Nagata N; Iwanari H; Kumagai H; Kusano-Arai O; Ikeda Y; Aritake K; Hamakubo T; Urade Y
PLoS One; 2017; 12(4):e0175452. PubMed ID: 28394950
[TBL] [Abstract][Full Text] [Related]
13. PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-
Werder RB; Lynch JP; Simpson JC; Zhang V; Hodge NH; Poh M; Forbes-Blom E; Kulis C; Smythe ML; Upham JW; Spann K; Everard ML; Phipps S
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743346
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2-Mediated DP2 and AKT Signal Regulate the Activation of Androgen Receptors in Human Dermal Papilla Cells.
Jeong KH; Jung JH; Kim JE; Kang H
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439547
[TBL] [Abstract][Full Text] [Related]
15. Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma.
Issahaku AR; Agoni C; Soremekun OS; Kubi PA; Kumi RO; Olotu FA; Soliman MES
Comb Chem High Throughput Screen; 2019; 22(8):521-533. PubMed ID: 31538888
[TBL] [Abstract][Full Text] [Related]
16. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
[TBL] [Abstract][Full Text] [Related]
17. Targeting the PGD
Kupczyk M; Kuna P
Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pro-adipogenic effects between prostaglandin (PG) D
Rahman MS; Syeda PK; Nartey MNN; Chowdhury MMI; Shimizu H; Nishimura K; Jisaka M; Shono F; Yokota K
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():71-79. PubMed ID: 30393164
[TBL] [Abstract][Full Text] [Related]
19. Investigational prostaglandin D2 receptor antagonists for airway inflammation.
Santini G; Mores N; Malerba M; Mondino C; Macis G; Montuschi P
Expert Opin Investig Drugs; 2016 Jun; 25(6):639-52. PubMed ID: 27094922
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
